Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313111) titled 'Thymoquinone as an add-on Therapy for the Management of Patients With Diabetic Peripheral Neuropathy' on Dec. 17, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Hawler Medical University

Condition: Diabetic Peripheral Neuropathy (DPN)

Intervention: Drug: stander treatment pregabalin

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: July 1, 2024

Target Sample Size: 50

Countries of Recruitment: Iraq

To know more, visit https://clinicaltrials....